About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Texas | 42,097 Studies Near You

Clinical TrialsTexas

Clinical Trials in Texas

Discover 42,097 clinical trials near Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 7061-7080 of 42,097 trials

RecruitingPrecision Ventilation vs Standard Care for Acute Respiratory Distress SyndromeThe goal of this interventional study is to compare standard mechanical ventilation to a lung-stress oriented ventilation strategy in patients with Acute Respiratory Distress…NCT06066502·Tucson, Arizona and 32 others

Find Trials by Condition in Texas

Breast Cancerin Texas Lung Cancerin Texas Prostate Cancerin Texas Colorectal Cancerin Texas Melanomain Texas Leukemiain Texas Lymphomain Texas Pancreatic Cancerin Texas Ovarian Cancerin Texas Brain Cancerin Texas Diabetesin Texas

Data from ClinicalTrials.govTerms

CompletedVigabatrin for the Treatment of Cocaine DependencyThe objective of this 26-28 week study is to demonstrate that the rate of cocaine dependent subjects treated with CPP-109 vigabatrin in addition to counseling, who completely stop…NCT01281202·Los Angeles, California and 12 others

Active not recruitingThe OPBC-07/microNAC StudyThe aim of this multicenter retrospective cohort study is to determine the safety of omission of axillary lymph node dissection in patients with residual micrometastases after…NCT06529302·Phoenix, Arizona and 83 others

CompletedPhysiological Response to Exercise: Sensor Evaluation at Specified ExertionsAssessment of sensor parameter in patients with heart failure.NCT01229137·Jonesboro, Arkansas and 13 others

TerminatedA Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant PatientsThe purpose of this study is to evaluate the efficacy, safety and tolerability of a single intravenous dose of ASP8597 in kidney transplant recipients.NCT01442337·Los Angeles, California and 18 others

CompletedBioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Fasting ConditionsThe purpose of this study is to compare the relative bioavailability of ciprofloxacin 1000 mg ER tablets of Dr.Reddy's with that of CIPRO® XR 1000 mg of Bayer Pharmaceuticals…NCT01372345·Houston, Texas

RecruitingAPPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in WomenThe APPROVE trial is a multi-centered, randomized controlled trial designed to assess differences in symptom improvement, quality of life, bladder symptoms, satisfaction with…NCT06797245·Birmingham, Alabama and 9 others

TerminatedEffects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary FibrosisThe purpose of this study is to establish single-dose tolerability of inhaled treprostinil sodium in idiopathic pulmonary fibrosis (IPF) patients with pulmonary hypertension, and…NCT00703339·La Jolla, California and 5 others

TerminatedSafety and Efficacy of MIW815 (ADU-S100) +/- Ipilimumab in Patients With Advanced/Metastatic Solid Tumors or LymphomasThe purpose of this study is to characterize the safety, tolerability, pharmacokinetics, pharmacodynamics and antitumor activity of MIW815 (ADU-S100) administered via intratumoral…NCT02675439·Aurora, Colorado and 6 others

RecruitingA Phase 2 Study of Radiotherapy-induced Immune Priming to Enhance Elranatamab (Elra) in Relapsed Refractory Multiple Myeloma (RRMM) With Extramedullary Disease (EMD) and Paramedullary Disease (PMD) "PRIME-EMD-PMD"To learn if low doses of radiation therapy can help the drug elranatamab enhance the killing effect of the cancer cells.NCT07382739·Houston, Texas

CompletedStudy of RVT-501 Topical Ointment in Pediatric Patients With Atopic DermatitisThis is a multi-center, randomized, vehicle controlled, double-blind Phase 2 study in pediatric patients age 2-17 years old with mild to moderate atopic dermatitis.NCT03394677·Los Angeles, California and 6 others

TerminatedStudy to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM SubjectsThe purpose of this study is to assess the safety and tolerability of VBI-1901 in subjects with recurrent malignant gliomas (glioblastoma, or GBM).NCT03382977·Irvine, California and 11 others

RecruitingCirculating Tumor DNAThis is a single-arm, phase II study examining elacestrant in the adjuvant treatment of patients with ER+ breast cancer who test positive for circulating tumor DNA (ctDNA) during…NCT06923527·New Haven, Connecticut and 6 others

CompletedPhase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS MutationsPhase II study to investigate the antitumor activity in terms of objective response rate (ORR) of tipifarnib in subjects with advanced tumors that carry HRAS mutations and for…NCT02383927·Los Angeles, California and 34 others

CompletedPhase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate SuppositoriesA randomized, multi-center, double-blind, three arm placebo-controlled study in male and non-pregnant, non-lactating female subjects aged 18 years to examine the safety and…NCT04469686·Huntsville, Alabama and 188 others

CompletedPlerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and ThymoglobulinThe goal of this clinical research study is to learn about the safety of AMD3100 (plerixafor) and G-CSF (filgrastim) in combination with fludarabine, busulfan, and an allogeneic…NCT00822770·Houston, Texas

UnknownPhase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid TumorsRBN-2397 inhibits PARP7, an enzyme that is switched on by cancer stresses, such as the toxins in cigarette smoke.NCT04053673·Aurora, Colorado and 14 others

CompletedA Phase II Study of MGCD0103 (MG-0103) in Patients With Refractory Chronic Lymphocytic LeukemiaIn this study, MGCD0103, a new anticancer drug under investigation, is given three times weekly to patients with refractory chronic lymphocytic leukemia.NCT00431873·Kansas City, Missouri and 12 others

CompletedPilot Study of X-82 in Patients With Wet AMDThe objective of this study is to evaluate the safety and preliminary biologic activity/efficacy of X-82 in patients with wet Age-related Macular Degeneration (AMD).NCT01674569·Beverly Hills, California and 4 others

Active not recruiting9-ING-41 in Patients With Advanced CancersGSK-3β is a potentially important therapeutic target in human malignancies.NCT03678883·Phoenix, Arizona and 65 others

PreviousPage 354 of 2105Next

Heart Diseasein Texas